Orchestra BioMed Holdings, Inc. - OBIO

SEC FilingsOur OBIO Tweets

About Gravity Analytica

Recent News

  • 05.12.2025 - Blog Post — First Quarter 2025 Business Highlights
  • 05.12.2025 - Blog Post — First Quarter 2025 Business Highlights
  • 05.12.2025 - Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones
  • 05.12.2025 - Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones
  • 05.12.2025 - Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones
  • 05.12.2025 - Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones
  • 05.12.2025 - Blog Post — First Quarter 2025 Business Highlights
  • 05.12.2025 - Blog Post — First Quarter 2025 Business Highlights
  • 05.09.2025 - Blog Post - AVIM Therapy Patent Portfolio Reaches New Milestone
  • 05.09.2025 - Blog Post - AVIM Therapy Patent Portfolio Reaches New Milestone

Recent Filings

  • 05.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 05.01.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.01.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
  • 04.30.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  • 04.30.2025 - ARS Annual Report to Security Holders
  • 04.30.2025 - DEF 14A Other definitive proxy statements